1. Home
  2. AHT vs MBRX Comparison

AHT vs MBRX Comparison

Compare AHT & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AHT

Ashford Hospitality Trust Inc

HOLD

Current Price

$3.88

Market Cap

26.2M

Sector

Real Estate

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$4.57

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHT
MBRX
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.2M
23.5M
IPO Year
2003
2016

Fundamental Metrics

Financial Performance
Metric
AHT
MBRX
Price
$3.88
$4.57
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$105.50
AVG Volume (30 Days)
344.8K
300.6K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,119,102,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$4.75
52 Week High
$10.35
$91.25

Technical Indicators

Market Signals
Indicator
AHT
MBRX
Relative Strength Index (RSI) 49.87 58.29
Support Level $3.05 $4.75
Resistance Level $4.80 $7.98
Average True Range (ATR) 0.34 0.63
MACD 0.17 -0.06
Stochastic Oscillator 51.89 55.81

Price Performance

Historical Comparison
AHT
MBRX

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides real estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: